Bay Street News, 2018

KP879 is being developed with serdexmethylphenidate, KemPharm’s prodrug of d-methylphenidate, to address a critical unmet need in the treatment of […]

DALLAS, Nov. 13, 2018 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced two […]

HOUSTON, Nov. 13, 2018 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (NASDAQ: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical […]

First dose cohort fully enrolled First patient enrolled with relapsed/refractory Mantle Cell Lymphoma achieved Partial Response (PR) to lowest dose […]

Company on track to initiate Phase III trials in late November NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) — Eyenovia, […]

280 additional ATM locations to display the TD brand TORONTO, Nov. 13, 2018 (GLOBE NEWSWIRE) — Parkland Fuel Corporation (“Parkland”), […]

TORONTO and CAMBRIDGE, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN); (OTCQB: ARFXF), a biotechnology company […]

VANCOUVER, British Columbia, Nov. 13, 2018 (GLOBE NEWSWIRE) — FIREWEED ZINC LTD. (“Fireweed” or the “Company”) (TSXV: FWZ) is pleased […]

Tetra Clarifies Estimated Fair Market Value of North Bud Farms Shares ORLEANS, Ontario, Nov. 13, 2018 (GLOBE NEWSWIRE) — Tetra […]

VANCOUVER, British Columbia, Nov. 13, 2018 (GLOBE NEWSWIRE) — Serengeti Resources Inc. (SIR: TSX-V) (“Serengeti” or “the Company”) is pleased […]